Canada Life
TNDM icon

Canada Life’s Tandem Diabetes Care TNDM Stock Holding History

Canada Life’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
53,286
-3,046
-5% -$66.2K ﹤0.01% 1352
2025
Q4 		$1.24M Hold
56,332
– – ﹤0.01% 1327
2025
Q3 		$664K Hold
56,332
– – ﹤0.01% 1547
2025
Q2 		$1.05M Buy
56,332
+3,054
+6% +$60.5K ﹤0.01% 1419
2025
Q1 		$1.02M Sell
53,278
-8,895
-14% -$260K ﹤0.01% 1432
2024
Q4 		$2.24M Hold
62,173
– – ﹤0.01% 1219
2024
Q3 		$2.64M Sell
62,173
-16,614
-21% -$704K ﹤0.01% 1179
2024
Q2 		$3.18M Sell
78,787
-855
-1% -$35.7K 0.01% 1053
2024
Q1 		$2.82M Sell
79,642
-1,238
-2% -$33.2K 0.01% 1077
2023
Q4 		$2.38M Buy
80,880
+1,473
+2% +$30.6K 0.01% 1157
2023
Q3 		$1.65M Buy
79,407
+690
+0.9% +$18.9K ﹤0.01% 1308
2023
Q2 		$1.93M Sell
78,717
-942
-1% -$30.3K ﹤0.01% 1220
2023
Q1 		$3.23M Buy
79,659
+19,491
+32% +$807K 0.01% 985
2022
Q4 		$2.71M Buy
60,168
+13,610
+29% +$616K 0.01% 1067
2022
Q3 		$2.23M Buy
46,558
+7,311
+19% +$401K 0.01% 1107
2022
Q2 		$2.32M Buy
39,247
+4,765
+14% +$391K 0.01% 1090
2022
Q1 		$4.12M Buy
34,482
+2,402
+7% +$280K 0.01% 837
2021
Q4 		$4.83M Buy
32,080
+2,475
+8% +$334K 0.01% 760
2021
Q3 		$3.56M Buy
29,605
+26,151
+757% +$2.88M 0.01% 830
2021
Q2 		$336K Sell
3,454
-486
-12% -$43.3K ﹤0.01% 1823
2021
Q1 		$345K Hold
3,940
– – ﹤0.01% 1822
2020
Q4 		$376K Hold
3,940
– – ﹤0.01% 1822
2020
Q3 		$447K Hold
3,940
– – ﹤0.01% 1700
2020
Q2 		$388K Buy
3,940
+401
+11% +$32K ﹤0.01% 1756
2020
Q1 		$229K Hold
3,539
– – ﹤0.01% 1789
2019
Q4 		$209K Buy
+3,539
New +$218K ﹤0.01% 1916
2019
Q3 		– Sell
-6,828
Closed -$440K – 2175
2019
Q2 		$440K Sell
6,828
-569
-8% -$36.7K ﹤0.01% 1811
2019
Q1 		$468K Buy
7,397
+1,509
+26% +$79.3K ﹤0.01% 1648
2018
Q4 		$216K Buy
+5,888
New +$208K ﹤0.01% 1915

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Canada Life's TNDM Position: Q1 2026 in Review

Canada Life reduced its Tandem Diabetes Care (TNDM) stake by 5.4% in Q1 2026, selling an estimated $66.2K and leaving 53,286 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Canada Life first reported a position in TNDM in Q4 2018 and has held it in 29 quarters since. The position peaked at $4.83M in Q4 2021. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Canada Life held 53,286 shares of Tandem Diabetes Care worth $1.02M as of Q1 2026.
  • Canada Life sold 3,046 Tandem Diabetes Care shares in Q1 2026, an estimated $66.2K.
  • Tandem Diabetes Care made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1352 holding.
  • Canada Life first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 29 quarters since.
  • Canada Life's Tandem Diabetes Care position peaked at $4.83M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.